Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Th17 cells are a distinct lineage of effector CD4+ T cells characterized by their production of interleukin (IL)-17. We demonstrate that Th17 cells also expressed IL-22, an IL-10 family member, at substantially higher amounts than T helper (Th)1 or Th2 cells. Similar to IL-17A, IL-22 expression was initiated by transforming growth factor β signaling in the context of IL-6 and other proinflammatory cytokines. The subsequent expansion of IL-22–producing cells was dependent on IL-23. We further demonstrate that IL-22 was coexpressed in vitro and in vivo with both IL-17A and IL-17F. To study a functional relationship among these cytokines, we examined the expression of antimicrobial peptides by primary keratinocytes treated with combinations of IL-22, IL-17A, and IL-17F. IL-22 in conjunction with IL-17A or IL-17F synergistically induced the expression of β-defensin 2 and S100A9 and additively enhanced the expression of S100A7 and S100A8. Collectively, we have identified IL-22 as a new cytokine expressed by Th17 cells that synergizes with IL-17A or IL-17F to regulate genes associated with skin innate immunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which are induced by IL-17 during infection (see section below) [28,31].”
From Host–Candida auris interactions in the skin (2026) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“S100A7 and S100A8 are strongly regulated by IL-17 and IL-22 in keratinocytes.25,39”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [39]
The cited source says what the claim attributes to it.
In the citing paper
“IL-17A and IL-22 are two members of the cytokine family with substantial roles in host defense and other immunoregulatory functions.25,36,39,69–72”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [39]
In the citing paper
“IL-22, another product of Th17 cells, appears to be protective in the bleomycin model (150)”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [150]
In the citing paper
“IL-1, TNFα, IFNγ, IL-17, and IL-22 are strong inducers of hBD2 and hBD3 expression.25,36,39”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087 · cited 1×
“Also, IL-23p19–defi cient mice are very susceptible to Citrobacter rodentium infection despite maintaining wild-type expression of IL-17A (7).”
BackgroundInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 2×
“Similar to IL-17A and IL-17F, IL-22 induces IL-6, CXCL8, and MCP-1 expression by fi broblast cells (1, 13, 14).”
BackgroundAggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D., & Cua, D. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030896 · Cited by 1,669 · cited 1×
“For example, IL-23p19–defi cient mice are completely resistant to disease in collagen-induced arthritis, whereas IL-17A– defi cient mice remain susceptible, albeit with a signifi cantly reduced incidence and severity (9, 10).”
BackgroundIL-22 Increases the Innate Immunity of Tissues
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., & Sabat, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.007 · Cited by 1,359 · cited 7×
“Keratinocytes treated with a combination of IL-17A and IL-17F enhanced S100A8, but did not further enhance expression of hBD-2, S100A7, or S100A9.”
BackgroundInfluential
Cited by
Items 101–200 of 1,006
Shen, H., Goodall, J. C., & Hill Gaston, J. S. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24568 · Cited by 516
Interleukin‐17 in host defence against bacterial, mycobacterial and fungal pathogens
Curtis, M. M., & Way, S. S. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.03017.x · Cited by 502
Microbial Translocation in the Pathogenesis of HIV Infection and AIDS
Marchetti, G., Tincati, C., & Silvestri, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00050-12 · Cited by 500
“As intestinal Th17 cells have an important role in antimicrobial immunity, particularly at mucosal sites (88–90), as well as in sustaining enterocyte homeostasis (89, 90), the preferential depletion of Th17 cells in pathogenic HIV/SIV infections may be involved in the damage to the structural and functional integrity…”
BackgroundMahmud, M. R., Akter, S., Tamanna, S. K., Mazumder, L., Esti, I. Z., Banerjee, S., Akter, S., Hasan, M. R., Acharjee, M., Hossain, M. S., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2096995 · Cited by 466
“The CD4+ Th17 cells produce the cytokine Interleukin 22 (IL-22), which enhances secretion of host AMPs.(86,87) The integrity of the intestinal barrier along with the action of mucus, immune cells, IgA, and antimicrobial peptides (AMPs) produced by epithelial cells prevents the entrance of gut bacteria into the bloodst…”
BackgroundBasic biology and role of interleukin‐17 in immunity and inflammation
Zenobia, C., & Hajishengallis, G. (2015) · Periodontology 2000 · doi:10.1111/prd.12083 · Cited by 470
“The figure was drawn based on information from several sources (5, 40, 42, 48, 80, 100, 106, 152).”
BackgroundMethodEstes, J. D., Harris, L. D., Klatt, N. R., Tabb, B., Pittaluga, S., Paiardini, M., Barclay, G. R., Smedley, J., Pung, R., Oliveira, K. M., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001052 · Cited by 477
“produce cytokines important for enterocyte proliferation and antibacterial defensins [49,50,51] and IL-17 has recently been shown to suppress Th1-mediated damage to gut epithelium.”
BackgroundMicrobial Translocation Across the GI Tract
Brenchley, J. M., & Douek, D. C. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075001 · Cited by 496
“Several therapeutic interventions aim to improve enterocyte homeostasis by the administration of cytokines such as IL-22, which is critical for maintenance of the structural barrier, particularly in the event of tissue damage (77, 85, 90, 211).”
BackgroundKhader, S. A., Gaffen, S. L., & Kolls, J. K. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.100 · Cited by 481
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
Brembilla, N. C., Senra, L., & Boehncke, W.-H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01682 · Cited by 475
Interleukin 17 is a chief orchestrator of immunity
Veldhoen, M. (2017) · Nature Immunology · doi:10.1038/ni.3742 · Cited by 475
Suárez-Fariñas, M., Dhingra, N., Gittler, J., Shemer, A., Cardinale, I., de Guzman Strong, C., Krueger, J. G., & Guttman-Yassky, E. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.046 · Cited by 483
The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut
Yoo, B. B., & Mazmanian, S. K. (2017) · Immunity · doi:10.1016/j.immuni.2017.05.011 · Cited by 474
“ILC3s are the first innate immune cells to expand in the GI tract after bacterial infection (Sonnenberg et al., 2011), and via IL-22, ILC3s have broadly protective effects on the intestinal epithelium (Liang et al., 2006; Lindemans et al., 2015; Sugimoto et al., 2008; Zheng et al., 2008).”
BackgroundThe role of IL-22 in intestinal health and disease
Keir, M. E., Yi, T., Lu, T. T., & Ghilardi, N. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20192195 · Cited by 464
Perera, G. K., Di Meglio, P., & Nestle, F. O. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132448 · Cited by 462
APC-derived cytokines and T cell polarization in autoimmune inflammation
Gutcher, I., & Becher, B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31720 · Cited by 459
Pathogenesis of psoriasis and development of treatment
Ogawa, E., Sato, Y., Minagawa, A., & Okuyama, R. (2018) · The Journal of Dermatology · doi:10.1111/1346-8138.14139 · Cited by 456
Th22 Cells Are an Important Source of IL-22 for Host Protection against Enteropathogenic Bacteria
Basu, R., O’Quinn, D. B., Silberger, D. J., Schoeb, T. R., Fouser, L., Ouyang, W., Hatton, R. D., & Weaver, C. T. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.024 · Cited by 454
“Originally described as a product of Th1 cells (Gurney, 2004), Th17 cells are also an important source of IL-22 (Liang et al., 2006; Zheng et al., 2007).”
BackgroundSelf-citationSignaling pathways and targeted therapies for psoriasis
Guo, J., Zhang, H., Lin, W., Lu, L., Su, J., & Chen, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01655-6 · Cited by 427
The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin
Weaver, C. T., Elson, C. O., Fouser, L. A., & Kolls, J. K. (2013) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130318 · Cited by 462
Self-citationLeppkes, M., Becker, C., Ivanov, I. I., Hirth, S., Wirtz, S., Neufert, C., Pouly, S., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.018 · Cited by 444
IL‐22, not simply a Th17 cytokine
Rutz, S., Eidenschenk, C., & Ouyang, W. (2013) · Immunological Reviews · doi:10.1111/imr.12027 · Cited by 435
“In mouse, however, Th17 cells, which produce IL-17 and express the transcription factor RORct, are the major source for IL-22 among Th cells (7, 9, 24), which is the reason that IL-22 is widely regarded as a Th17 cytokine today (Fig.”
BackgroundInfluentialTh17 cells: Effector T cells with inflammatory properties
Korn, T., Oukka, M., Kuchroo, V., & Bettelli, E. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.007 · Cited by 445
“Although not tested, it is also possible that this pathology results from increased IL-22 production since this cytokine was recently shown to be preferentially produced by Th17 cells [28,29].”
BackgroundZaba, L. C., Fuentes-Duculan, J., Eungdamrong, N. J., Abello, M. V., Novitskaya, I., Pierson, K. C., Gonzalez, J., Krueger, J. G., & Lowes, M. A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.194 · Cited by 442
“Th17 cells produce IL-17 and IL-22, and have other important downstream pro-inflammatory effects in skin (Liang et al., 2006; Zheng et al., 2007).”
Acute Lower Respiratory Tract Infection
Mizgerd, J. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmra074111 · Cited by 441
Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers
Gruosso, T., Gigoux, M., Manem, V. S. K., Bertos, N., Zuo, D., Perlitch, I., Saleh, S. M. I., Zhao, H., Souleimanova, M., Johnson, R. M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci96313 · Cited by 439
The aryl hydrocarbon receptor in immunity
Esser, C., Rannug, A., & Stockinger, B. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.06.005 · Cited by 447
Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs)
Dijksteel, G. S., Ulrich, M. M. W., Middelkoop, E., & Boekema, B. K. H. L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.616979 · Cited by 428
The IL-23-IL-17 axis in inflammatory arthritis
Lubberts, E. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.53 · Cited by 442
Immunity against Staphylococcus aureus cutaneous infections
Miller, L. S., & Cho, J. S. (2011) · Nature Reviews Immunology · doi:10.1038/nri3010 · Cited by 434
“Both IL-17 and IL-22 have been shown to induce keratinocyte production of antimicrobial peptides (such as the human cathelicidin LL-37, human β-defensin 2 and psoriasin (also known as S100A7)”
BackgroundTh1 and Th17 cells: Adversaries and collaborators
Damsker, J. M., Hansen, A. M., & Caspi, R. R. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05133.x · Cited by 419
Carrier, Y., Ma, H.-L., Ramon, H. E., Napierata, L., Small, C., O'Toole, M., Young, D. A., Fouser, L. A., Nickerson-Nutter, C., Collins, M., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.234 · Cited by 425
“This is in agreement with our previous report that IL-22 has a synergistic/additive effect on the induction of antimicrobial peptides by IL-17A or IL-17F (Liang et al., 2006).”
InfluentialSelf-citationIL-17 disrupts corneal barrier following desiccating stress
De Paiva, C. S., Chotikavanich, S., Pangelinan, S. B., Pitcher, J. D., Fang, B., Zheng, X., Ma, P., Farley, W. J., Siemasko, K. F., Niederkorn, J. Y., et al. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.5 · Cited by 422
The IL-20 subfamily of cytokines — from host defence to tissue homeostasis
Rutz, S., Wang, X., & Ouyang, W. (2014) · Nature Reviews Immunology · doi:10.1038/nri3766 · Cited by 416
AHR in the intestinal microenvironment: safeguarding barrier function
Stockinger, B., Shah, K., & Wincent, E. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00430-8 · Cited by 403
Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis
Su, X., Gao, Y., & Yang, R. (2022) · Cells · doi:10.3390/cells11152296 · Cited by 424
Pathophysiology of psoriasis: Recent advances on IL-23 and Th17 cytokines
Fitch, E., Harper, E., Skorcheva, I., Kurtz, S. E., & Blauvelt, A. (2007) · Current Rheumatology Reports · doi:10.1007/s11926-007-0075-1 · Cited by 415
Wolk, K., Haugen, H. S., Xu, W., Witte, E., Waggie, K., Anderson, M., vom Baur, E., Witte, K., Warszawska, K., Philipp, S., et al. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0457-0 · Cited by 412
“Moreover, it strongly increases the expression of antimicrobial proteins [7, 11, 13–15].”
BackgroundEssentials of Th17 cell commitment and plasticity
Muranski, P., & Restifo, N. P. (2013) · Blood · doi:10.1182/blood-2012-09-378653 · Cited by 383
“IL-22 and IL-17 synergistically trigger production of many antimicrobial peptides and proteins (b-defensins, S100 proteins, regenerating islet-derived protein 3 g, and lipocalin 2).(88) The IL-22 receptor (IL-22R) is predominantly expressed by cells of nonhematopoietic origin (keratinocytes, hepatocytes, and enterocyt…”
BackgroundIL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage
Stritesky, G. L., Yeh, N., & Kaplan, M. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.5948 · Cited by 417
“Even with our culture conditions optimized for maintaining IL-17 secretion, IL-21 levels still decrease over time, and IL-22 levels are lower than in some previous reports (Fig.”
ResultInfluentialScriba, T. J., Kalsdorf, B., Abrahams, D.-A., Isaacs, F., Hofmeister, J., Black, G., Hassan, H. Y., Wilkinson, R. J., Walzl, G., Gelderbloem, S. J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1962 · Cited by 410
“Murine data suggest that IL-22 is coexpressed with IL-17 by Th17 cells (38, 42).”
BackgroundResultIL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice
Haak, S., Croxford, A. L., Kreymborg, K., Heppner, F. L., Pouly, S., Becher, B., & Waisman, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35997 · Cited by 399
Regulation of the T cell response
Romagnani, S. (2006) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2006.02606.x · Cited by 401
Lazarevic, V., Chen, X., Shim, J.-H., Hwang, E.-S., Jang, E., Bolm, A. N., Oukka, M., Kuchroo, V. K., & Glimcher, L. H. (2011) · Nature Immunology · doi:10.1038/ni.1969 · Cited by 385
“T H 17 cells produce IL-17A, IL-17F, IL-21 and IL-22, which protect the host against bacterial and fungal infections encountered at mucosal surface”
Wolk, K., Witte, E., Witte, K., Warszawska, K., & Sabat, R. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0188-x · Cited by 395
“This is the case for the induction of antibacterial proteins [ 36 ]a nd CXCL8 [67].”
BackgroundPsoriasiform dermatitis is driven by IL-36–mediated DC-keratinocyte crosstalk
Tortola, L., Rosenwald, E., Abel, B., Blumberg, H., Schäfer, M., Coyle, A. J., Renauld, J.-C., Werner, S., Kisielow, J., & Kopf, M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63451 · Cited by 405
“Il1r1 –/– , Il36r –/– , and WT mice were treated with Aldara, as described in the legend to Figure 1 (42).”
Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A
Sonnenberg, G. F., Nair, M. G., Kirn, T. J., Zaph, C., Fouser, L. A., & Artis, D. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092054 · Cited by 380
“As IL-17A and IL-22 are coexpressed and have been shown to act cooperatively (Liang et al., 2006; Aujla et al., 2008), we investigated the influence of IL-17A on IL-22 expression and function in the lung by using Il17a/ mice.”
InfluentialSelf-citationTc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge
Hamada, H., Garcia-Hernandez, M. D. L. L., Reome, J. B., Misra, S. K., Strutt, T. M., McKinstry, K. K., Cooper, A. M., Swain, S. L., & Dutton, R. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801814 · Cited by 387
“The IFN- -, granzyme B-, FoxP3-positive cells and cells positive for IL-22 come mainly from memory cells and decrease in number when generated from CD44low rather than unselected CD8 T cells.”
InfluentialImmunopathogenesis of psoriasis
Sabat, R., Philipp, S., Höflich, C., Kreutzer, S., Wallace, E., Asadullah, K., Volk, H., Sterry, W., & Wolk, K. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00629.x · Cited by 373
Human T Cells That Are Able to Produce IL-17 Express the Chemokine Receptor CCR6
Singh, S. P., Zhang, H. H., Foley, J. F., Hedrick, M. N., & Farber, J. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.214 · Cited by 371
“Although we used combinations of cytokines for producing Th17 cells that have worked well using cells from mice (35), the percentages of IL-17-staining cells in our cultures were low.”
MethodNew insights of T cells in the pathogenesis of psoriasis
Cai, Y., Fleming, C., & Yan, J. (2012) · Cellular & Molecular Immunology · doi:10.1038/cmi.2012.15 · Cited by 389
‘Yin–Yang’ functions of transforming growth factor‐β and T regulatory cells in immune regulation
Wan, Y. Y., & Flavell, R. A. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00565.x · Cited by 380
“Th17 cells produce IL-17 and IL-22, and they are critical for the induction of experimental autoimmune encephalitis (EAE) in mice.”
BackgroundAn overview of IL-17 function and signaling
Gaffen, S. L. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.017 · Cited by 382
IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis
Krueger, J. G., Fretzin, S., Suárez-Fariñas, M., Haslett, P. A., Phipps, K. M., Cameron, G. S., McColm, J., Katcherian, A., Cueto, I., White, T., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.04.024 · Cited by 383
Innate Lymphoid Cells in Inflammation and Immunity
McKenzie, A. N. J., Spits, H., & Eberl, G. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.006 · Cited by 368
Maintenance of intestinal homeostasis by mucosal barriers
Okumura, R., & Takeda, K. (2018) · Inflammation and Regeneration · doi:10.1186/s41232-018-0063-z · Cited by 366
“IL-17 and IL-22 produced by Th17 cells or ILC3 upregulate the secretion of AMPs and Reg3 family proteins by IECs, and induce the fucosylation of cell membrane proteins on IECs of the small intestine, which work to regulate commensal and pathogenic bacteria [20, 33].”
BackgroundFollicular helper T cells in immunity and systemic autoimmunity
Craft, J. E. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.58 · Cited by 375
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
Schinocca, C., Rizzo, C., Fasano, S., Grasso, G., La Barbera, L., Ciccia, F., & Guggino, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637829 · Cited by 360
“Synergism between IL-17 and TNF-α has been shown to activate the production of pro-inflammatory mediators, such as IL-1β, IL-6, IL-8, PGE2, and matrix metalloproteinases (MMPs), promoting progression of early inflammation toward a chronic arthritis (205, 206).”
BackgroundCytokine-mediated regulation of antimicrobial proteins
Kolls, J. K., McCray, P. B., & Chan, Y. R. (2008) · Nature Reviews Immunology · doi:10.1038/nri2433 · Cited by 363
Liang, S. C., Long, A. J., Bennett, F., Whitters, M. J., Karim, R., Collins, M., Goldman, S. J., Dunussi-Joannopoulos, K., Williams, C. M. M., Wright, J. F., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7791 · Cited by 371
“10 mice using MACS positive and negative selection (Miltenyi Biotec) as previously described (17).”
BackgroundMethodSelf-citationInterleukin-17 and innate immunity in infections and chronic inflammation
Isailovic, N., Daigo, K., Mantovani, A., & Selmi, C. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.04.006 · Cited by 363
T Helper Cell Differentiation, Heterogeneity, and Plasticity
Zhu, J. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a030338 · Cited by 351
“IL-22 is a critical cytokine for stimulating cells at mucosal barriers to produce antimicrobial peptides and proinflammatory cytokines and chemokines (Liang et al. 2006).”
BackgroundCytokinocytes: the diverse contribution of keratinocytes to immune responses in skin
Jiang, Y., Tsoi, L. C., Billi, A. C., Ward, N. L., Harms, P. W., Zeng, C., Maverakis, E., Kahlenberg, J. M., & Gudjonsson, J. E. (2020) · JCI Insight · doi:10.1172/jci.insight.142067 · Cited by 348
Evolutionary divergence and functions of the human interleukin (IL) gene family
Brocker, C., Thompson, D., Matsumoto, A., Nebert, D. W., & Vasiliou, V. (2010) · Human Genomics · doi:10.1186/1479-7364-5-1-30 · Cited by 368
“126 IL22 facilitates defence against microbial pathogens by initiating the release of antimicrobial peptides associated with host defence, such as defensin-b2 and S100A7.”
BackgroundBone marrow and the control of immunity
Zhao, E., Xu, H., Wang, L., Kryczek, I., Wu, K., Hu, Y., Wang, G., & Zou, W. (2012) · Cellular & Molecular Immunology · doi:10.1038/cmi.2011.47 · Cited by 356
d'Enfert, C., Kaune, A.-K., Alaban, L.-R., Chakraborty, S., Cole, N., Delavy, M., Kosmala, D., Marsaux, B., Fróis-Martins, R., Morelli, M., et al. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa060 · Cited by 347
Zindl, C. L., Lai, J.-F., Lee, Y. K., Maynard, C. L., Harbour, S. N., Ouyang, W., Chaplin, D. D., & Weaver, C. T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300318110 · Cited by 350
“Early studies demonstrated that IL-17CD4 T cells (Th17 cells) produce IL-22 (1, 11).”
BackgroundHamada, S., Umemura, M., Shiono, T., Tanaka, K., Yahagi, A., Begum, M. D., Oshiro, K., Okamoto, Y., Watanabe, H., Kawakami, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3456 · Cited by 353
“It was reported that Th17 cells coexpress IL-22, and that IL-17A and IL-22 cooperatively induced expression of anti-microbial peptides including -defensins and S100A8/9 molecules (40).”
BackgroundInterleukin-17 and its expanding biological functions
Xu, S., & Cao, X. (2010) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.21 · Cited by 357
Th17 cells in immunity to Candida albicans
Hernández-Santos, N., & Gaffen, S. L. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.04.008 · Cited by 361
“In skin, IL-17 signals cooperatively with IL-22 to induce AMPs such as S100A7 and b-defensin 2 (BD2) in keratinocytes and epithelial cells (Liang et al., 2006).”
Distinct regulation of interleukin‐17 in human T helper lymphocytes
Chen, Z., Tato, C. M., Muul, L., Laurence, A., & O'Shea, J. J. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22866 · Cited by 358
Th17 Cells in Cancer: The Ultimate Identity Crisis
Bailey, S. R., Nelson, M. H., Himes, R. A., Li, Z., Mehrotra, S., & Paulos, C. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00276 · Cited by 334
Alcorn, J. F., Crowe, C. R., & Kolls, J. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135926 · Cited by 348
Guilloteau, K., Paris, I., Pedretti, N., Boniface, K., Juchaux, F., Huguier, V., Guillet, G., Bernard, F.-X., Lecron, J.-C., & Morel, F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902464 · Cited by 353
“IL-17A and IL-22 synergize in the upregulation of b-defensin 2 (BD2) and S100A9 production (24).”
BackgroundCharacterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
Johansen, C., Usher, P. A., Kjellerup, R. B., Lundsgaard, D., Iversen, L., & Kragballe, K. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08902.x · Cited by 352
Monin, L., & Gaffen, S. L. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028522 · Cited by 339
“Indeed, in 2005, a third Th cell subset was described that produced IL17A, IL-17F, as well as IL-21, IL-22, and granulocyte macrophage colony-stimulating factor (GM-CSF) (Park et al. 2005; Liang et al. 2006; Korn et al. 2007; Nurieva et al. 2007), and hence came to be known as “Th17.””
BackgroundInfluentialFritz, J. H., Le Bourhis, L., Sellge, G., Magalhaes, J. G., Fsihi, H., Kufer, T. A., Collins, C., Viala, J., Ferrero, R. L., Girardin, S. E., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.03.009 · Cited by 331
The Immunology of Psoriasis-Current Concepts in Pathogenesis
Sieminska, I., Pieniawska, M., & Grzywa, T. M. (2024) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-024-08991-7 · Cited by 346
“It was demonstrated that IL-17 and IL-22 can be co-expressed by T H 17 cells and synergize in the induction of the expression of AMPs by KCs in vitro [208].”
BackgroundInfluenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice.
Kudva, A., Scheller, E. V., Robinson, K. M., Crowe, C. R., Choi, S. M., Slight, S. R., Khader, S. A., Dubin, P. J., Enelow, R. I., Kolls, J. K., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002194 · Cited by 346
IL-27 Blocks RORc Expression to Inhibit Lineage Commitment of Th17 Cells
Diveu, C., McGeachy, M. J., Boniface, K., Stumhofer, J. S., Sathe, M., Joyce-Shaikh, B., Chen, Y., Tato, C. M., McClanahan, T. K., de Waal Malefyt, R., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801162 · Cited by 333
“IL-23, which shares the p40 subunit with IL-12, drives the expansion of a pathogenic Th17 cell population characterized by production of IL-17A, IL-17F, IL-22, TNF- , IL-6 and diverse chemokines (5, 7).”
BackgroundDi Stefano, A., Caramori, G., Gnemmi, I., Contoli, M., Vicari, C., Capelli, A., Magno, F., D'Anna, S. E., Zanini, A., Brun, P., et al. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03965.x · Cited by 336
Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers
Lyadova, I. V., & Panteleev, A. V. (2015) · Mediators of Inflammation · doi:10.1155/2015/854507 · Cited by 327
“IL-23, IL1𝛽, and TNF-𝛼 maintain and amplify Th17 cells.”
BackgroundInterleukin 17A: Toward a new understanding of psoriasis pathogenesis
Lynde, C. W., Poulin, Y., Vender, R., Bourcier, M., & Khalil, S. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.12.036 · Cited by 335
IL-17 and Th17 cells in tuberculosis
Torrado, E., & Cooper, A. M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.004 · Cited by 327
“In vivo and in vitro differentiation of Th17 cells leads to the development of cells expressing only IL-17, IL-22 and cells that coexpress both cytokines [6], suggesting that IL-22 production is not restricted to Th17 cells but most likely induced by Th17 differentiation factors.”
BackgroundInfluentialRecent advances in IL-22 biology
Zenewicz, L. A., & Flavell, R. A. (2011) · International Immunology · doi:10.1093/intimm/dxr001 · Cited by 333
Kreymborg, K., Etzensperger, R., Dumoutier, L., Haak, S., Rebollo, A., Buch, T., Heppner, F. L., Renauld, J.-C., & Becher, B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8098 · Cited by 333
“(18), we found IL-22 to be highly expressed by Th17 cells.”
BackgroundGaffen, S. L., & Hajishengallis, G. (2008) · Journal of Dental Research · doi:10.1177/154405910808700908 · Cited by 334
“The positive feedback loop mediated by IL-21 is vital in vivo, since Th17 cells develop poorly in IL-21deficient mice (Nurieva et al., 2007).”
InfluentialLow Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis
Guttman-Yassky, E., Lowes, M. A., Fuentes-Duculan, J., Zaba, L. C., Cardinale, I., Nograles, K. E., Khatcherian, A., Novitskaya, I., Carucci, J. A., Bergman, R., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7420 · Cited by 331
“In contrast, IFN- did not appear to have an effect on the induction of the innate defense proteins, but up-regulated HLA-DRA, CXCL9, CXCL10, and CXCL11, genes that are known to be induced by IFN- (32) (Fig.”
ResultInfluentialRes, P. C. M., Piskin, G., de Boer, O. J., van der Loos, C. M., Teeling, P., Bos, J. D., & Teunissen, M. B. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014108 · Cited by 328
“Both cytokines are proinflammatory and may have a role in the pathogenesis of psoriasis, as both have features in common among others their ability to activate keratinocytes [49,50].”
BackgroundSeiderer, J., Elben, I., Diegelmann, J., Glas, J., Stallhofer, J., Tillack, C., Pfennig, S., Jürgens, M., Schmechel, S., Konrad, A., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20339 · Cited by 329
Crhanova, M., Hradecka, H., Faldynova, M., Matulova, M., Havlickova, H., Sisak, F., & Rychlik, I. (2011) · Infection and Immunity · doi:10.1128/iai.01375-10 · Cited by 317
“Enteritidis infection, mature Th17 cells then produced IL-17 and IL-22 and increased the resistance of epithelial cells by increasing the production of antimicrobial peptides (14) and by recovery of damaged tissue stimulated by IL-22 (32).”
BackgroundNistala, K., Moncrieffe, H., Newton, K. R., Varsani, H., Hunter, P., & Wedderburn, L. R. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23291 · Cited by 334
“Th17 cells (36,37) and has been implicated in RA (38).”
BackgroundIL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections
Slaats, J., ten Oever, J., van de Veerdonk, F. L., & Netea, M. G. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005973 · Cited by 317
Scanning the Immunopathogenesis of Psoriasis
Chiricozzi, A., Romanelli, P., Volpe, E., Borsellino, G., & Romanelli, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010179 · Cited by 320
Liu, J. Z., Jellbauer, S., Poe, A. J., Ton, V., Pesciaroli, M., Kehl-Fie, T. E., Restrepo, N. A., Hosking, M. P., Edwards, R. A., Battistoni, A., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.01.017 · Cited by 328
“The antimicrobial protein calprotectin, whose activity is dependent on zinc and manganese binding, is induced during bacterial and fungal infections in response to the cytokines IL-17 and IL-22 (Conti et al., 2009; Corbin et al., 2008; Kehl-Fie et al., 2011; Liang et al., 2006; Urban et al., 2009; Zheng et al., 2008).”
InfluentialDifferentiation, phenotype, and function of interleukin-17–producing human Vγ9Vδ2 T cells
Caccamo, N., La Mendola, C., Orlando, V., Meraviglia, S., Todaro, M., Stassi, G., Sireci, G., Fournié, J. J., & Dieli, F. (2011) · Blood · doi:10.1182/blood-2011-01-331298 · Cited by 307
The role of IL‐23 and the IL‐23/TH17 immune axis in the pathogenesis and treatment of psoriasis
Girolomoni, G., Strohal, R., Puig, L., Bachelez, H., Barker, J., Boehncke, W. H., & Prinz, J. C. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14433 · Cited by 313
“More specifically, CD4 and CD8 T cells with an interleukin-17 (IL-17) secretory phenotype (T-17 cells) are important contributors owing to their production of the pro-inflammatory cytokines IL-17, IL-22, and tumor necrosis factor (TNF).(35,36) Also, a shift in the T-cell pool during psoriasis in which regulatory T cel…”
Backgroundγδ T cells: an important source of IL-17
Roark, C. L., Simonian, P. L., Fontenot, A. P., Born, W. K., & O’Brien, R. L. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.006 · Cited by 325
“They also can produce IL-21, IL-22, tumor necrosis factor (TNFα), IL-6, and granulocyte-macrophage colony stimulating factor (GM-CSF), but usually not IFNγ or IL-4 [5–13].”
BackgroundIL-17 as a future therapeutic target for rheumatoid arthritis
van den Berg, W. B., & Miossec, P. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.179 · Cited by 317
“Apart from IL-17, T H 17 cells are a major source of IL-21 (an amplification factor in T H 17 cell generation) and IL-22, which has a role in host defense and probably in autoimmune pathology”
BackgroundColonna, M. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.008 · Cited by 307
“gIIIb, RegIIIg, and lipocalin-2 (Aujla et al., 2008; Liang et al., 2006; Wolk et al., 2004; Zheng et al., 2008).”
BackgroundImmunomodulatory effects of cyclophosphamide and implementations for vaccine design
Sistigu, A., Viaud, S., Chaput, N., Bracci, L., Proietti, E., & Zitvogel, L. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0245-0 · Cited by 305
“IL-17F, IL-21 [57], IL-22 [58] regulated by the expression of two transcription factors, RAR-related orphan nuclear”
Background
Metadata
- Authors
- Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A.
- Affiliations
- 1Inflammation
- 2Antibody Technologies Group, Wyeth Research, Cambridge, MA 02140
- Wyeth (US)
- ORCID
- Collins, Mary
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-09-18
- Volume
- 203
- Issue
- 10
- Pages
- 2271-2279
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118116
- OpenAlex
- W2139008734
- Cited by
- 2,330
- References
- 19
- Citations by year
- 2026: 57 · 2025: 61 · 2024: 80 · 2023: 74 · 2022: 93 · 2021: 118 · 2020: 127 · 2019: 104 · 2018: 104 · 2017: 112 · 2016: 126 · 2015: 132 · 2014: 145 · 2013: 147 · 2012: 156
- FWCI
- 47.05
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Keywords
- IL-22, IL-17A, IL-17F, Th17 cells, antimicrobial peptides, human beta-defensin 2, S100A7, S100A8, S100A9, keratinocytes, skin innate immunity, IL-23, interleukin-6, TGF-beta signaling, cytokine synergy
- MeSH terms
- Interleukin-22, Animals, Cell Differentiation, Immunity, Innate, Interleukins, Mice, Transgenic, Signal Transduction, CD4-Positive T-Lymphocytes, Keratinocytes, Polymerase Chain Reaction, Transforming Growth Factor beta, Interleukin-17, Antimicrobial Cationic Peptides, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.